{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:56:25Z","timestamp":1792569385853,"version":"4.5.0"},"reference-count":121,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>Adult-onset Still's disease (AOSD) is a rare but clinically well-known polygenic systemic autoinflammatory disease. In this review, we aim to present frontiers in the pathogenesis, clinical features, diagnosis, biomarkers, disease course, prognosis, and treatment in AOSD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Data sources:<\/jats:title>\n            <jats:p>We retrieved information from the PubMed database up to July 2019, using various search terms and relevant words, including AOSD and Still's disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Study selection:<\/jats:title>\n            <jats:p>We included data from peer-reviewed journals. Both basic and clinical studies were selected.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Pathogenesis of AOSD involves genetic background, infectious triggers, and immunopathogenesis, mainly the activation of macrophages and neutrophils followed by a cytokine storm. Diagnosis and prognosis evaluation of AOSD is still challenging; therefore, there is an urgent need to identify better biomarkers. Biologic agents, including interleukin (IL)-1\u03b2, IL-6, and tumor necrosis factor-\u03b1 antagonists in the treatment of AOSD, have good prospect.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This review highlights the advances in pathogenesis, potential biomarkers, disease course, and treatment in AOSD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000000538","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T06:38:53Z","timestamp":1574663933000},"page":"2856-2864","source":"Crossref","is-referenced-by-count":67,"title":["Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review"],"prefix":"10.1097","volume":"132","author":[{"given":"Meng-Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Chao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-De","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong-Yi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,12,5]]},"reference":[{"key":"R1-20230813","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.autrev.2017.07.017","article-title":"How I treat patients with adult onset Still's disease in clinical practice","volume":"16","author":"Govoni","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R2-20230813","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2014.01.011","article-title":"Diagnosis and classification of adult Still's disease","volume":"48-49","author":"Mahroum","year":"2014","journal-title":"J Autoimmun"},{"key":"R3-20230813","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still's disease","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J Autoimmun"},{"key":"R4-20230813","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","article-title":"Still's disease in the adult","volume":"30","author":"Bywaters","year":"1971","journal-title":"Ann Rheum Dis"},{"key":"R5-20230813","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/ard.54.7.587","article-title":"Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France","volume":"54","author":"Magadur-Joly","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"R6-20230813","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2188\/jea.7.221","article-title":"Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan","volume":"7","author":"Wakai","year":"1997","journal-title":"J Epidemiol"},{"key":"R7-20230813","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/03009740510026616","article-title":"Epidemiology and outcome of adult-onset Still's disease in Northern Norway","volume":"35","author":"Evensen","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"R8-20230813","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1742-1241.2007.01393.x","article-title":"Adult-onset Still's disease","volume":"63","author":"Cagatay","year":"2009","journal-title":"Int J Clin Pract"},{"key":"R9-20230813","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2019.04.004","article-title":"Racial\/ethnic variations in morbidity and mortality in adult onset Still's disease: an analysis of national dataset","author":"Mehta","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"R10-20230813","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R11-20230813","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/art.1780241203","article-title":"HLA-Bw35 and prognosis in adult Still's disease","volume":"24","author":"Terkeltaub","year":"1981","journal-title":"Arthritis Rheum"},{"key":"R12-20230813","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"R13-20230813","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/art.1780290316","article-title":"Adult-onset Still's disease. Disease course and HLA associations","volume":"29","author":"Wouters","year":"1986","journal-title":"Arthritis Rheum"},{"key":"R14-20230813","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/rheumatology\/40.12.1398","article-title":"Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease","volume":"40","author":"Fujii","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"R15-20230813","first-page":"489","article-title":"Association between HLA-DR B1 and clinical features of adult onset Still's disease in Korea","volume":"21","author":"Joung","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"R16-20230813","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.3899\/jrheum.090316","article-title":"Functional association of interleukin 18 gene -607 (C\/A) promoter polymorphisms with disease course in Chinese patients with adult-onset Still's disease","volume":"36","author":"Chen","year":"2009","journal-title":"J Rheumatol"},{"key":"R17-20230813","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/sj.gene.6363922","article-title":"Association between adult-onset Still's disease and interleukin-18 gene polymorphisms","volume":"3","author":"Sugiura","year":"2002","journal-title":"Genes Immun"},{"key":"R18-20230813","doi-asserted-by":"crossref","first-page":"e13394","DOI":"10.1097\/MD.0000000000013394","article-title":"Serum amyloid A1 (SAA1) gene polymorphisms in Japanese patients with adult-onset Still's disease","volume":"97","author":"Yashiro","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R19-20230813","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar4239","article-title":"A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease","volume":"15","author":"Wang","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"(3 Suppl 77)","key":"R20-20230813","first-page":"60","article-title":"MEFV gene mutations and their clinical significance in Korean patients with adult-onset Still's disease","volume":"31","author":"Kim","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"R21-20230813","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/cei.12463","article-title":"Increased prevalence of MEFV exon 10 variants in Japanese patients with adult-onset Still's disease","volume":"179","author":"Nonaka","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"R22-20230813","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3899\/jrheum.071254","article-title":"Association of Fcgamma receptor polymorphisms with adult onset Still's disease in Korea","volume":"36","author":"Woo","year":"2009","journal-title":"J Rheumatol"},{"issue":"(1-2)","key":"R23-20230813","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12026-014-8561-9","article-title":"Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart","volume":"61","author":"Jamilloux","year":"2015","journal-title":"Immunol Res"},{"key":"R24-20230813","first-page":"1058","article-title":"Adult Still's disease: a multicenter survey of Japanese patients","volume":"17","author":"Ohta","year":"1990","journal-title":"J Rheumatol"},{"key":"R25-20230813","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/ard.47.9.764","article-title":"Adult onset Still's disease and viral infections","volume":"47","author":"Wouters","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"R26-20230813","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/ard.59.6.490c","article-title":"Rubella infection in adult onset Still's disease","volume":"59","author":"Escudero","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"R27-20230813","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0950-3579(05)80283-3","article-title":"Adult-onset Still's disease","volume":"5","author":"van de Putte","year":"1991","journal-title":"Bailliere's Clin Rheumatol"},{"key":"R28-20230813","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.1086\/319342","article-title":"Adult Still's disease associated with Mycoplasma pneumoniae infection","volume":"32","author":"Perez","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R29-20230813","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.berh.2004.05.004","article-title":"Adult-onset Still's disease","volume":"18","author":"Kadar","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R30-20230813","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3389\/fimmu.2019.00898","article-title":"Cytomegalovirus infection may trigger adult-onset Still's disease onset or relapses","volume":"10","author":"Jia","year":"2019","journal-title":"Front Immunol"},{"key":"R31-20230813","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset Still's disease","volume":"14","author":"Feist","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"R32-20230813","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/rheumatology\/38.5.477","article-title":"High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still's disease","volume":"38","author":"Matsui","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"R33-20230813","first-page":"396","article-title":"Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease","volume":"25","author":"Hoshino","year":"1998","journal-title":"J Rheumatol"},{"key":"R34-20230813","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/14737159.2019.1615449","article-title":"The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still's disease","volume":"19","author":"Jung","year":"2019","journal-title":"Expert Rev Mol Diagn"},{"key":"R35-20230813","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3899\/jrheum.161354","article-title":"Elevated expression of the NLRP3 inflammasome and its correlation with disease activity in adult-onset Still disease","volume":"44","author":"Hsieh","year":"2017","journal-title":"J Rheumatol"},{"key":"R36-20230813","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ncprheum0681","article-title":"Primer: inflammasomes and interleukin 1beta in inflammatory disorders","volume":"4","author":"Church","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"R37-20230813","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13075-018-1800-z","article-title":"Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still's disease","volume":"21","author":"Hu","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"R38-20230813","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.autrev.2007.01.016","article-title":"Ferritin in autoimmune diseases","volume":"6","author":"Zandman-Goddard","year":"2007","journal-title":"Autoimmun Rev"},{"key":"R39-20230813","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/hep.22716","article-title":"Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta\/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells","volume":"49","author":"Ruddell","year":"2009","journal-title":"Hepatology"},{"key":"R40-20230813","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-291X(90)91466-6","article-title":"Interleukin 1 induces ferritin heavy chain in human muscle cells","volume":"169","author":"Wei","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"R41-20230813","doi-asserted-by":"crossref","first-page":"14572","DOI":"10.1016\/S0021-9258(18)77341-9","article-title":"Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1","volume":"265","author":"Rogers","year":"1990","journal-title":"J Biol Chem"},{"key":"R42-20230813","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.V99.10.3505","article-title":"Regulation of ferritin genes and protein","volume":"99","author":"Torti","year":"2002","journal-title":"Blood"},{"key":"R43-20230813","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.blre.2008.08.001","article-title":"Ferritin for the clinician","volume":"23","author":"Knovich","year":"2009","journal-title":"Blood Rev"},{"key":"R44-20230813","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.autrev.2015.01.004","article-title":"Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease","volume":"14","author":"Ruscitti","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R45-20230813","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/cei.12738","article-title":"The CD68(+)\/H-ferritin(+) cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: correlation with disease severity and implication for pathogenesis","volume":"183","author":"Ruscitti","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"R46-20230813","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/cei.12826","article-title":"H-ferritin and CD68(+) \/H-ferritin(+) monocytes\/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease","volume":"186","author":"Ruscitti","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"R47-20230813","first-page":"298405","article-title":"Ferritin in adult-onset still's disease: just a useful innocent bystander?","volume":"2012","author":"Mehta","year":"2012","journal-title":"Int J Inflam"},{"key":"R48-20230813","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/03009742.2011.644325","article-title":"Neutrophil CD64 is upregulated in patients with active adult-onset Still's disease","volume":"41","author":"Komiya","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"R49-20230813","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10067-012-1952-1","article-title":"Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome","volume":"31","author":"Kasama","year":"2012","journal-title":"Clin Rheumatol"},{"key":"R50-20230813","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.181058","article-title":"Neutrophil extracellular traps may contribute to the pathogenesis in adult-onset Still's disease","author":"Ahn","year":"2019","journal-title":"J Rheumatol"},{"key":"R51-20230813","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/prd.12025","article-title":"Neutrophil extracellular traps as a new paradigm in innate immunity: friend or foe?","volume":"63","author":"Cooper","year":"2013","journal-title":"Periodontology 2000"},{"key":"R52-20230813","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fimmu.2017.00081","article-title":"Neutrophil extracellular traps and its implications in inflammation: an overview","volume":"8","author":"Delgado-Rizo","year":"2017","journal-title":"Front Immunol"},{"key":"R53-20230813","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3899\/jrheum.111500","article-title":"Natural killer cell cytolytic function in Korean patients with adult-onset Still's disease","volume":"39","author":"Park","year":"2012","journal-title":"J Rheumatol"},{"key":"R54-20230813","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.181192","article-title":"Characteristics of circulating natural killer cells and their interferon-gamma production in active adult-onset Still disease","author":"Shimojima","year":"2019","journal-title":"J Rheumatol"},{"key":"R55-20230813","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1002\/art.34514","article-title":"Natural killer T cell deficiency in active adult-onset Still's disease: correlation of deficiency of natural killer T cells with dysfunction of natural killer cells","volume":"64","author":"Lee","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R56-20230813","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/ard.2003.013680","article-title":"Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease","volume":"63","author":"Chen","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R57-20230813","first-page":"2422","article-title":"Serum cytokine profiles in patients with adult onset Still's disease","volume":"30","author":"Choi","year":"2003","journal-title":"J Rheumatol"},{"key":"R58-20230813","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/rheumatology\/keq284","article-title":"Potential role of Th17 cells in the pathogenesis of adult-onset Still's disease","volume":"49","author":"Chen","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R59-20230813","doi-asserted-by":"crossref","first-page":"2058738418791284","DOI":"10.1177\/2058738418791284","article-title":"Characteristic patterns of HLA presentation and T cell differentiation in adult-onset Still's disease","volume":"32","author":"Jung","year":"2018","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R60-20230813","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/03008200903461462","article-title":"The associations of circulating CD4+CD25high regulatory T cells and TGF-beta with disease activity and clinical course in patients with adult-onset Still's disease","volume":"51","author":"Chen","year":"2010","journal-title":"Connect Tissue Res"},{"key":"R61-20230813","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-019-04642-x","article-title":"Elevated serum levels of interleukin-10 in adult-onset Still's disease are associated with disease activity","author":"Sun","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R62-20230813","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13075-018-1555-6","article-title":"Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity","volume":"20","author":"Chi","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"R63-20230813","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.berh.2008.08.006","article-title":"Adult-onset Still disease","volume":"22","author":"Fautrel","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R64-20230813","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/0019-5359.53169","article-title":"Adult-onset Still's disease: a review","volume":"63","author":"Owlia","year":"2009","journal-title":"Indian J Med Sci"},{"key":"R65-20230813","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"R66-20230813","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset still disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R67-20230813","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3899\/jrheum.100766","article-title":"Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still's disease in a Chinese population","volume":"38","author":"Jiang","year":"2011","journal-title":"J Rheumatol"},{"key":"R68-20230813","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.semarthrit.2017.07.005","article-title":"Validation of the Fautrel classification criteria for adult-onset Still's disease","volume":"47","author":"Lebrun","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"R69-20230813","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Rosario","year":"2013","journal-title":"BMC Med"},{"key":"R70-20230813","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9343(99)80318-0","article-title":"A controlled study of the long-term prognosis of adult Still's disease","volume":"98","author":"Sampalis","year":"1995","journal-title":"Am J Med"},{"key":"R71-20230813","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10067-010-1516-1","article-title":"Clinical features and prognosis in adult-onset Still's disease: a study of 104 cases","volume":"29","author":"Kong","year":"2010","journal-title":"Clin Rheumatol"},{"key":"R72-20230813","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3899\/jrheum.080365","article-title":"Clinical features and prognosis of adult-onset still's disease: 61 cases from China","volume":"36","author":"Zeng","year":"2009","journal-title":"J Rheumatol"},{"key":"R73-20230813","first-page":"890","article-title":"Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease","volume":"21","author":"Van Reeth","year":"1994","journal-title":"J Rheumatol"},{"key":"R74-20230813","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.59.5.347","article-title":"Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease","volume":"59","author":"Vignes","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"R75-20230813","first-page":"322","article-title":"Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease","volume":"28","author":"Fautrel","year":"2001","journal-title":"J Rheumatol"},{"key":"R76-20230813","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clim.2016.05.010","article-title":"Cytokine profile in adult-onset Still's disease: comparison with systemic juvenile idiopathic arthritis","volume":"169","author":"Inoue","year":"2016","journal-title":"Clin Immunol"},{"key":"R77-20230813","first-page":"2189","article-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"key":"R78-20230813","first-page":"156890","article-title":"IL-18 serum level in adult onset Still's disease: a marker of disease activity","volume":"2012","author":"Colafrancesco","year":"2012","journal-title":"Int J Inflam"},{"key":"R79-20230813","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3899\/jrheum.130575","article-title":"Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis","volume":"41","author":"Priori","year":"2014","journal-title":"J Rheumatol"},{"key":"R80-20230813","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/03009742.2013.824023","article-title":"Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease","volume":"43","author":"Jung","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"R81-20230813","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/rheumatology\/kew300","article-title":"Elevated serum levels of free interleukin-18 in adult-onset Still's disease","volume":"55","author":"Girard","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R82-20230813","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41927-019-0053-z","article-title":"Comparative study of interleukin-18 (IL-18) serum levels in adult onset Still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity","volume":"3","author":"Kudela","year":"2019","journal-title":"BMC Rheumatol"},{"key":"R83-20230813","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.1780300209","article-title":"Adult-onset Still's disease. Clinical course and outcome","volume":"30","author":"Cush","year":"1987","journal-title":"Arthritis Rheum"},{"key":"R84-20230813","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10067-005-0138-5","article-title":"A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis","volume":"25","author":"Pay","year":"2006","journal-title":"Clin Rheumatol"},{"key":"R85-20230813","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.semarthrit.2010.12.006","article-title":"The evolution of adult-onset Still disease: an observational and comparative study in a cohort of 76 Italian patients","volume":"41","author":"Colina","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"R86-20230813","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","article-title":"Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions","volume":"13","author":"Maria","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R87-20230813","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13075-019-1838-6","article-title":"Adult-onset Still's disease biological treatment strategy may depend on the phenotypic dichotomy","volume":"21","author":"Vercruysse","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"R88-20230813","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.49.5.283","article-title":"Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 years","volume":"49","author":"Cabane","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"R89-20230813","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/art.27532","article-title":"Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease","volume":"62","author":"Franchini","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R90-20230813","first-page":"1055","article-title":"Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases","volume":"61","author":"Wouters","year":"1986","journal-title":"Q J Med"},{"key":"R91-20230813","first-page":"17","article-title":"Adult-onset Still's disease: current challenges and future prospects","volume":"8","author":"Siddiqui","year":"2016","journal-title":"Open Access Rheumatol"},{"key":"R92-20230813","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/s10165-008-0126-0","article-title":"Cyclosporin A treatment for Japanese patients with severe adult-onset Still's disease","volume":"19","author":"Mitamura","year":"2009","journal-title":"Mod Rheumatol"},{"key":"R93-20230813","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3109\/14397595.2014.933997","article-title":"Usefulness of tacrolimus for refractory adult-onset still's disease: report of six cases","volume":"26","author":"Nakamura","year":"2016","journal-title":"Mod Rheumatol"},{"key":"R94-20230813","first-page":"245","article-title":"High toxicity of sulfasalazine in adult-onset Still's disease","volume":"18","author":"Jung","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"R95-20230813","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1586\/1744666X.2014.962996","article-title":"Methotrexate: an old new drug in autoimmune disease","volume":"10","author":"Cipriani","year":"2014","journal-title":"Exp Rev Clin Immunol"},{"key":"R96-20230813","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.berh.2016.08.003","article-title":"Adult-onset Still's disease: advances in the treatment","volume":"30","author":"Castaneda","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R97-20230813","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/1744666X.2017.1375853","article-title":"Biologic drugs in adult onset Still's disease: a systematic review and meta-analysis of observational studies","volume":"13","author":"Ruscitti","year":"2017","journal-title":"Exp Rev Clin Immunol"},{"key":"R98-20230813","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/1744666X.2017.1332994","article-title":"Treatment of adult-onset still's disease: up to date","volume":"13","author":"Yoo","year":"2017","journal-title":"Exp Rev Clin Immunol"},{"key":"R99-20230813","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/1744666X.2018.1536548","article-title":"Anakinra for the treatment of adult-onset Still's disease","volume":"14","author":"Castaneda","year":"2018","journal-title":"Exp Rev Clin Immunol"},{"key":"R100-20230813","first-page":"2345","article-title":"Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety","volume":"8","author":"Hong","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"R101-20230813","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/14397595.2017.1416924","article-title":"Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still's disease: a meta-analysis","volume":"28","author":"Ma","year":"2018","journal-title":"Mod Rheumatol"},{"key":"R102-20230813","doi-asserted-by":"crossref","first-page":"13477","DOI":"10.1038\/s41598-017-13639-y","article-title":"A pilot study on tocilizumab for treating refractory adult-onset Still's disease","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"R103-20230813","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10067-015-3108-6","article-title":"Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease","volume":"35","author":"Guo","year":"2016","journal-title":"Clin Rheumatol"},{"key":"R104-20230813","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3899\/jrheum.120079","article-title":"Serum S100A8\/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease","volume":"39","author":"Kim","year":"2012","journal-title":"J Rheumatol"},{"key":"R105-20230813","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.3899\/jrheum.140651","article-title":"Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease","volume":"41","author":"Bae","year":"2014","journal-title":"J Rheumatol"},{"key":"R106-20230813","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12891-015-0569-3","article-title":"The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease","volume":"16","author":"Chen","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"R107-20230813","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s10067-016-3314-x","article-title":"Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash","volume":"35","author":"Jung","year":"2016","journal-title":"Clin Rheumatol"},{"key":"R108-20230813","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12026-014-8563-7","article-title":"sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia","volume":"60","author":"Colafrancesco","year":"2014","journal-title":"Immunol Res"},{"key":"R109-20230813","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.clinbiochem.2008.01.008","article-title":"The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease","volume":"41","author":"Zou","year":"2008","journal-title":"Clin Biochem"},{"key":"R110-20230813","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/art.21164","article-title":"Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease","volume":"53","author":"Chen","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R111-20230813","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1038\/s41598-017-04086-w","article-title":"Upregulation of circulating microRNA-134 in adult-onset Still's disease and its use as potential biomarker","volume":"7","author":"Liao","year":"2017","journal-title":"Sci Rep"},{"key":"R112-20230813","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.3389\/fimmu.2018.03099","article-title":"Plasma microRNA profiles as a potential biomarker in differentiating adult-onset Still's disease from sepsis","volume":"9","author":"Hu","year":"2018","journal-title":"Front Immunol"},{"key":"R113-20230813","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13075-015-0773-4","article-title":"Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease","volume":"17","author":"Han","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R114-20230813","article-title":"The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease","author":"Han","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"R115-20230813","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","article-title":"Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"76","author":"Bracaglia","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R116-20230813","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3899\/jrheum.170020","article-title":"Serum levels of interleukin 33 and soluble ST2 are associated with the extent of disease activity and cutaneous manifestations in patients with active adult-onset Still's disease","volume":"44","author":"Han","year":"2017","journal-title":"J Rheumatol"},{"key":"R117-20230813","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1741-7015-10-84","article-title":"Germinal center kinase-like kinase (GLK\/MAP4K3) expression is increased in adult-onset Still's disease and may act as an activity marker","volume":"10","author":"Chen","year":"2012","journal-title":"BMC Med"},{"key":"R118-20230813","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/14397595.2017.1422231","article-title":"Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still's disease: a multicenter retrospective study","volume":"28","author":"Kirino","year":"2018","journal-title":"Mod Rheumatol"},{"key":"R119-20230813","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10067-013-2220-8","article-title":"Serum beta2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease","volume":"32","author":"Wakabayashi","year":"2013","journal-title":"Clin Rheumatol"},{"key":"R120-20230813","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3349\/ymj.2014.55.3.753","article-title":"Delta neutrophil index as an early marker for differential diagnosis of adult-onset Still's disease and sepsis","volume":"55","author":"Park","year":"2014","journal-title":"Yonsei Med J"},{"key":"R121-20230813","article-title":"Up-regulation of CD64 expression on monocytes in patients with active adult-onset Still disease: a possible biomarker of disease activity","author":"Shimizu","year":"2018","journal-title":"J Clin Rheumatol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T08:23:18Z","timestamp":1691914998000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000000538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":121,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000000538","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]}}}